While the extension of the time-action profile is necessary for a once-weekly basalinsulin, the expectation of possible prolonged and/or recurrent hypoglycemia are concerns.Ideally, a glucose-sensing basal insulin, in which insulin activity is controlled bylevels of circulating glucose, could alleviate or prevent hypoglycemia concerns. This evidence concerns the gene INS and Hypoglycemia.